On May 23, 2024, MyMD Pharmaceuticals, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.96 USD | -5.77% |
|
+0.51% | -9.26% |
17/06 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
23/05 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.96 USD | -5.77% | +0.51% | 1.66Cr | ||
1.84 USD | +0.55% | -5.15% | 42.46L | ||
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.26% | 1.66Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- MyMD Pharmaceuticals, Inc. amended terms of the transaction